You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 17, May 7, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Grand Rounds at the Clinical Center of the National Institutes of Health
 This Article
 •References
 •Full text PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Evaluating Coronary Heart Disease Risk

Tiles in the Mosaic

Jeffrey M. Hoeg, MD

JAMA. 1997;277(17):1387-1390.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

SELECTED CASE

An asymptomatic 34-year-old white man was referred to the Lipid Clinic of the National Heart, Lung, and Blood Institute for atherosclerotic cardiovascular disease risk assessment. His father died at the age of 39 years of a myocardial infarction, and his 2 paternal uncles developed symptomatic coronary artery disease by the age of 40 years. The search for conventional cardiovascular disease risk factors was unrevealing. The patient exercised regularly and had never smoked tobacco products. Physical examination revealed a normotensive man within 5% of his ideal body weight. His fasting concentrations of blood glucose (5.33 mmol/L [96 mg/dL]), low-density lipoprotein cholesterol (LDL-C) (1.76 mmol/L [68 mg/ dL]) and high-density lipoprotein cholesterol (HDL-C) (1.06 mmol/L [41 mg/dL]) were all within normal limits. However, his fasting plasma triglyceride concentration was increased (6.64 mmol/L [588 mg/dL]) as was his apolipoprotein B concentration at 3.90 mmol/L (151 mg/dL) (normal range, 1.94-3.33 mmol/L [75-129 . . . [Full Text PDF of this Article]


Author Affiliations

From the Section of Cell Biology, Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.


Footnotes

Reprints: Jeffrey M. Hoeg, MD, Bldg 10, Room 7N115, National Institutes of Health, 10 Center Dr, MSC 1666, Bethesda, MD 20892-1666 (e-mail: Jeff@mdb. nhlbi.nih.gov).

Grand Rounds at the Warren Grant Magnuson Clinical Center of the National Institutes of Health section editors: John I. Gallin, MD, the Clinical Center of the National Institutes of Health, Bethesda, Md; David S. Cooper, MD, Contributing Editor, JAMA.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.